BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9069299)

  • 1. Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer.
    Minsky BD; Cohen AM; Enker WE; Saltz L; Guillem JG; Paty PB; Kelsen DP; Kemeny N; Ilson D; Bass J; Conti J
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):289-95. PubMed ID: 9069299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer.
    Grann A; Minsky BD; Cohen AM; Saltz L; Guillem JG; Paty PB; Kelsen DP; Kemeny N; Ilson D; Bass-Loeb J
    Dis Colon Rectum; 1997 May; 40(5):515-22. PubMed ID: 9152176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of preoperative 5-fluorouracil, high-dose leucovorin, and sequential radiation therapy for unresectable rectal cancer.
    Minsky BD; Cohen AM; Kemeny N; Enker WE; Kelsen DP; Saltz L; Frankel J
    Cancer; 1993 Jun; 71(11):3486-92. PubMed ID: 8490898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.
    Movsas B; Hanlon AL; Lanciano R; Scher RM; Weiner LM; Sigurdson ER; Hoffman JP; Eisenberg BL; Cooper HS; Provins S; Coia LR
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):43-50. PubMed ID: 9747818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer.
    Harrison LB; Minsky BD; Enker WE; Mychalczak B; Guillem J; Paty PB; Anderson L; White C; Cohen AM
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):325-30. PubMed ID: 9788411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy.
    Minsky BD; Cohen AM; Kemeny N; Enker WE; Kelsen DP; Reichman B; Saltz L; Sigurdson ER; Frankel J
    J Clin Oncol; 1992 Jan; 10(1):79-84. PubMed ID: 1727928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable rectal cancer.
    Minsky BD; Cohen AM; Kemeny N; Enker WE; Kelsen DP; Schwartz G; Saltz L; Dougherty J; Frankel J; Wiseberg J
    Int J Radiat Oncol Biol Phys; 1993 Apr; 25(5):821-7. PubMed ID: 8478232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of postoperative 5-FU, high-dose leucovorin, and sequential radiation therapy for clinically resectable rectal cancer.
    Minsky BD; Cohen AM; Enker WE; Kelsen DP; Kemeny N; Frankel J
    Cancer Invest; 1995; 13(1):1-7. PubMed ID: 7834464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
    Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114.
    Tepper JE; O'Connell MJ; Petroni GR; Hollis D; Cooke E; Benson AB; Cummings B; Gunderson LL; Macdonald JS; Martenson JA
    J Clin Oncol; 1997 May; 15(5):2030-9. PubMed ID: 9164215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancer.
    Minsky B; Cohen A; Enker W; Kelsen D; Kemeny N; Ilson D; Guillem J; Saltz L; Frankel J; Conti J
    Cancer; 1994 Jan; 73(2):273-80. PubMed ID: 8293388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
    Fountzilas G; Zisiadis A; Dafni U; Konstantaras C; Hatzitheoharis G; Liaros A; Athanassiou E; Dombros N; Dervenis C; Basdanis G; Gamvros O; Souparis A; Briasoulis E; Samantas E; Kappas A; Kosmidis P; Skarlos D; Pavlidis N
    Ann Oncol; 1999 Jun; 10(6):671-6. PubMed ID: 10442189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of 5-fluorouracil and intraoperative electron beam radiation therapy on the outcome of patients with locally advanced primary rectal and rectosigmoid cancer.
    Nakfoor BM; Willett CG; Shellito PC; Kaufman DS; Daly WJ
    Ann Surg; 1998 Aug; 228(2):194-200. PubMed ID: 9712564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of 5-fluorouracil and leucovorin by continuous infusion chronotherapy and pelvic radiotherapy in patients with locally advanced or recurrent rectal cancer.
    Parulekar W; de Marsh RW; Wong R; Mendenhall W; Davey P; Zlotecki R; Berry S; Rout WR; Bjarnason GA
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1487-95. PubMed ID: 15050328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
    de la Torre A; García-Berrocal MI; Arias F; Mariño A; Valcárcel F; Magallón R; Regueiro CA; Romero J; Zapata I; de la Fuente C; Fernández-Lizarbe E; Vergara G; Belinchón B; Veiras M; Molerón R; Millán I
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):102-10. PubMed ID: 17869446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancer.
    Minsky BD; Kemeny N; Cohen AM; Enker WE; Kelsen DP; Reichman B; Saltz L; Sigurdson ER; Frankel J
    Cancer; 1991 Jun; 67(11):2859-66. PubMed ID: 2025851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative chemoradiation in locally advanced rectal cancer: a comparison of bolus 5-fluorouracil/leucovorin and capecitabine.
    Yoney A; Isikli L
    Saudi J Gastroenterol; 2014; 20(2):102-7. PubMed ID: 24705147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Sandwich" preoperative and postoperative combined chemotherapy and radiation in tethered and fixed rectal cancer: impact of treatment intensity on local control and survival.
    Chan AK; Wong AO; Langevin JM; Jenken DA; Khoo R; Heine JA; Buie WD; Johnson DR
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):629-37. PubMed ID: 9112462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma.
    Grann A; Feng C; Wong D; Saltz L; Paty PP; Guillem JG; Cohen AM; Minsky BD
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):987-95. PubMed ID: 11240239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
    Landry JC; Feng Y; Prabhu RS; Cohen SJ; Staley CA; Whittington R; Sigurdson ER; Nimeiri H; Verma U; Benson AB
    Oncologist; 2015 Jun; 20(6):615-6. PubMed ID: 25926352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.